Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Hanrahan

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Respiratory Care|October 3, 2009
Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solutionAndrea Bauer, Paul McGlynn, Li Li Bovet, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative studyAh-Fong Hoo, Carol Dezateux, John P Hanrahan, et al.
Respiratory Care|October 30, 2009
The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulatorAndrea Bauer, Paul McGlynn, Li Li Bovet, et al.
Journal of Hazardous Materials|October 12, 2010
Development of chemically engineered porous metal oxides for phosphate removalPaul Delaney, Colm McManamon, John P Hanrahan, et al.
COPD|February 9, 2008
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trialsJohn P Hanrahan, Nicola A Hanania, William J Calhoun, et al.
Clinical Therapeutics|May 3, 2007
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialRudolf A Baumgartner, Nicola A Hanania, William J Calhoun, et al.
Journal of Hazardous Materials|September 23, 2008
Large pore bi-functionalised mesoporous silica for metal ion pollution treatmentAoife M Burke, John P Hanrahan, David A Healy, et al.
Medicine|November 18, 2008
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterolJohn P Hanrahan, Donna R Grogan, Rudolf A Baumgartner, et al.
Journal of Separation Science|March 12, 2010
Preparation, characterisation and modification of carbon-based monolithic rods for chromatographic applicationsAli H Eltmimi, Leon Barron, Aran Rafferty, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2008
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjectsKenneth Tripp, William K McVicar, Parameswaran Nair, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Respiratory Care|October 3, 2009
Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solutionAndrea Bauer, Paul McGlynn, Li Li Bovet, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative studyAh-Fong Hoo, Carol Dezateux, John P Hanrahan, et al.
Respiratory Care|October 30, 2009
The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulatorAndrea Bauer, Paul McGlynn, Li Li Bovet, et al.
Journal of Hazardous Materials|October 12, 2010
Development of chemically engineered porous metal oxides for phosphate removalPaul Delaney, Colm McManamon, John P Hanrahan, et al.
COPD|February 9, 2008
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trialsJohn P Hanrahan, Nicola A Hanania, William J Calhoun, et al.
Clinical Therapeutics|May 3, 2007
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialRudolf A Baumgartner, Nicola A Hanania, William J Calhoun, et al.
Journal of Hazardous Materials|September 23, 2008
Large pore bi-functionalised mesoporous silica for metal ion pollution treatmentAoife M Burke, John P Hanrahan, David A Healy, et al.
Medicine|November 18, 2008
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterolJohn P Hanrahan, Donna R Grogan, Rudolf A Baumgartner, et al.
Journal of Separation Science|March 12, 2010
Preparation, characterisation and modification of carbon-based monolithic rods for chromatographic applicationsAli H Eltmimi, Leon Barron, Aran Rafferty, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2008
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjectsKenneth Tripp, William K McVicar, Parameswaran Nair, et al.
Pageof 4